Literature DB >> 3978645

Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects.

J J Nordlund, J Kirkwood, B M Forget, A Scheibner, D M Albert, E Lerner, G W Milton.   

Abstract

We examined 296 patients with a history of melanoma and 145 controls for the presence of atypical (dysplastic) nevi. We found that 34% of patients with melanoma and 7% of controls had clinically atypical (dysplastic) nevi. Patients and controls with atypical (dysplastic) nevi had more nevi than the subjects without. The number of nevi varies negatively and significantly with age (r = 0.37, P less than 0.001). Ten % of patients and controls had hypopigmented halos around one or more nevi. Both patients and comparison subjects with atypical (dysplastic) nevi tended to have this subtle variant of halo nevi more often than those without (r = 0.17, P less than 0.01). The number of nevi on the irides of melanoma patients was greater than that in the comparison group. The results of this study suggest that patients with a melanoma exhibit more commonly cutaneous and ocular pigmentary lesions than comparison subjects without a melanoma.

Entities:  

Mesh:

Year:  1985        PMID: 3978645

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

Review 1.  Risk factors for intraocular melanoma and occupational exposure.

Authors:  J M Lutz; I A Cree; A J Foss
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

2.  Cigarette smoking and malignant melanoma: a case-control study.

Authors:  Maria C Kessides; Lee Wheless; Judith Hoffman-Bolton; Sandra Clipp; Rhoda M Alani; Anthony J Alberg
Journal:  J Am Acad Dermatol       Date:  2010-03-23       Impact factor: 11.527

Review 3.  State of melanoma: an historic overview of a field in transition.

Authors:  Vikram C Gorantla; John M Kirkwood
Journal:  Hematol Oncol Clin North Am       Date:  2014-06       Impact factor: 3.722

Review 4.  Role of primary care in the prevention of malignant melanoma.

Authors:  N Johnson; D Mant; J Newton; P L Yudkin
Journal:  Br J Gen Pract       Date:  1994-11       Impact factor: 5.386

5.  Use of oral N-acetylcysteine for protection of melanocytic nevi against UV-induced oxidative stress: towards a novel paradigm for melanoma chemoprevention.

Authors:  Agnessa Gadeliya Goodson; Murray A Cotter; Pamela Cassidy; Mark Wade; Scott R Florell; Tong Liu; Kenneth M Boucher; Douglas Grossman
Journal:  Clin Cancer Res       Date:  2009-11-17       Impact factor: 12.531

Review 6.  Melanoma risk factors and atypical moles.

Authors:  M L Williams; R W Sagebiel
Journal:  West J Med       Date:  1994-04

7.  Study of Nevi in Children (SONIC): baseline findings and predictors of nevus count.

Authors:  Susan A Oliveria; Jaya M Satagopan; Alan C Geller; Stephen W Dusza; Martin A Weinstock; Marianne Berwick; Marilyn Bishop; Maureen K Heneghan; Allan C Halpern
Journal:  Am J Epidemiol       Date:  2008-11-10       Impact factor: 4.897

8.  Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study.

Authors:  V Bataille; J A Bishop; P Sasieni; A J Swerdlow; E Pinney; K Griffiths; J Cuzick
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

9.  Inter-clinician agreement on the recognition of clinical pigmentary characteristics of patients with cutaneous malignant melanoma. Studies of melanocytic nevi, VI.

Authors:  G C Roush; R L Barnhill; M S Ernstoff; J M Kirkwood
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

10.  Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX.

Authors:  G C Roush; R L Barnhill
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.